Journal of magnetic resonance imaging : JMRI
-
J Magn Reson Imaging · Mar 2015
Multicenter StudyPhase 3 efficacy and safety trial of gadobutrol, a 1.0 molar macrocyclic MR imaging contrast agent, in patients referred for contrast-enhanced MR imaging of the central nervous system.
Gadobutrol is a 1.0 M macrocyclic magnetic resonance imaging (MRI) contrast agent. A study was performed to evaluate the efficacy and safety of gadobutrol-enhanced versus unenhanced imaging for central nervous system (CNS) lesion visualization and detection. ⋯ Gadobutrol 1.0M is an effective and well-tolerated contrast agent for CNS MRI.